Showing 1 - 2 results of 2 for search 'Zannikos, P.' Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Author
  • Zannikos, P.
Showing 1 - 2 results of 2 for search 'Zannikos, P.', query time: 0.07s Refine Results
  1. 1
    First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18
    First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18
    by Finkel JC, Goldberg J, Rosenburg R, Ariyawansa J, Sun T, Ochs-Ross R, Zannikos P, Zhang L, Etropolski M
    Published 2019-06-01
    Get full text
    Article
  2. 2
    Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study
    Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study
    by Harris, K.C, Kubitza, D., Lesko, L.J, Li, J.S, McCrindle, B.W, Michelson, A.D, Nessel, K., Pina, L.M, Weber, T., Willmann, S., Yang, H., Zannikos, P., Zhou, W., Zhu, P.
    Published 2022
    Call Number: Loading...
    Located: Loading...
    View Fulltext in Publisher
    Article
Search Tools: Get RSS Feed — Email this Search

Related Subjects

Anticoagulants Area Under Curve Article Body Weights and Measures Child Child, Preschool Female Fontan Procedure Fontan procedure Humans Male Models, Biological Partial Thromboplastin Time Prospective Studies Prothrombin Time Rivaroxaban Thrombosis acetylsalicylic acid activated partial thromboplastin time adult anticoagulant agent area under the curve biological model blood clotting factor 10a inhibitor body weight child clinical trial controlled study drug dose regimen drug efficacy

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...